Cargando…

Prognostic Role of BRAF Mutation in Stage II/III Colorectal Cancer Receiving Curative Resection and Adjuvant Chemotherapy: A Meta-Analysis Based on Randomized Clinical Trials

BACKGROUND AND OBJECTIVE: Studies examining the prognostic value of the BRAF mutation on relapse-free survival (RFS), disease-free survival (DFS) and overall survival (OS) in stage II/III colorectal cancer (CRC) patients receiving curative resection and adjuvant chemotherapy so far showed discrepant...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Lizhen, Dong, Caixia, Cao, Ying, Fang, Xuefeng, Zhong, Chenhan, Li, Dan, Yuan, Ying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4854379/ https://www.ncbi.nlm.nih.gov/pubmed/27138801 http://dx.doi.org/10.1371/journal.pone.0154795

Ejemplares similares

Impact of Adjuvant Chemotherapy in Patients With Curatively Resected Stage IV Colorectal Cancer
por: Kobayashi, Hirotoshi, et al.
Publicado: (2015)

Cost-effectiveness of adjuvant chemotherapy with uracil–tegafur for curatively resected stage III rectal cancer
por: Hisashige, A, et al.
Publicado: (2008)

The effect of comorbidity on the use of adjuvant chemotherapy and type of regimen for curatively resected stage III colon cancer patients
por: Hsieh, Mei‐Chin, et al.
Publicado: (2016)

Right- and left-sided stage III colon cancers present different prognostic outcomes of oxaliplatin-based adjuvant chemotherapy after curative resection
por: Peng, Jianhong, et al.
Publicado: (2018)

Prognostic Value of EGFR Expression for Patients With Stage III Colorectal Cancer Receiving Fluoropyrimidine Metronomic Maintenance Therapy After Radical Resection and Adjuvant Oxaliplatin-Based Chemotherapy
por: Huang, Ching-Wen, et al.
Publicado: (2021)

S-1 Based Doublet as an Adjuvant Chemotherapy for Curatively Resected Stage III Gastric Cancer: Results from the Randomized Phase III POST Trial
por: Lee, Choong-kun, et al.
Publicado: (2019)

Primary Tumor Resection Plus Chemotherapy versus Chemotherapy Alone for Colorectal Cancer Patients with Synchronous Bone Metastasis
por: Li, Yanqing, et al.
Publicado: (2023)

Apurinic/apyrimidinic endonuclease 1 is associated with poor prognosis after curative resection followed by adjuvant chemotherapy in patients with stage III colon cancer
por: Song, Ji Hyeong, et al.
Publicado: (2022)

Multicenter, phase II clinical trial of peptide vaccination with oral chemotherapy following curative resection for stage III colorectal cancer
por: Kawamura, Junichiro, et al.
Publicado: (2018)

Association between adjuvant chemotherapy and survival in stage I gastric cancer patients after curative resection
por: Chen, Qiuying, et al.
Publicado: (2023)

Cost-effectiveness of adjuvant chemotherapy for curatively resected gastric cancer with S-1
por: Hisashige, Akinori, et al.
Publicado: (2013)

Adjuvant chemotherapy in curatively resected rectal cancer: How valid are the data?
por: Manzini, Giulia, et al.
Publicado: (2020)

The use of adjuvant chemotherapy is not associated with recurrence or cancer-specific death following curative resection for stage III rectal cancer: a competing risks analysis
por: Ng, Kheng-Seong, et al.
Publicado: (2023)

Gut microbiome associated with chemotherapy-induced diarrhea from the CapeOX regimen as adjuvant chemotherapy in resected stage III colorectal cancer
por: Fei, Zuo, et al.
Publicado: (2019)

The presence of a systemic inflammatory response predicts poorer survival in patients receiving adjuvant 5-FU chemotherapy following potentially curative resection for colorectal cancer
por: Crozier, J E M, et al.
Publicado: (2006)

Bcl-xL as a poor prognostic biomarker and predictor of response to adjuvant chemotherapy specifically in BRAF-mutant stage II and III colon cancer
por: Dunne, Philip D., et al.
Publicado: (2018)

Nutritional status predicts adjuvant chemotherapy outcomes for stage III colorectal cancer
por: Ihara, Keisuke, et al.
Publicado: (2019)

Validation of the conventional Glasgow Prognostic Score and development of the improved Glasgow Prognostic Score in patients with stage 0‐III colorectal cancer after curative resection
por: Ishikawa, Satoshi, et al.
Publicado: (2021)

A Prognostic Nomogram and Heat Map to Predict Survival in Stage II/III Gastric Cancer Patients After Curative Gastrectomy Followed by Adjuvant Chemotherapy
por: Shi, Litong, et al.
Publicado: (2022)

Is there a survival benefit from adjuvant chemotherapy for patients with liver oligometastases from colorectal cancer after curative resection?
por: Pan, Zhizhong, et al.
Publicado: (2018)

Adjuvant Chemotherapy for Stage III Colon Cancer
por: Taieb, Julien, et al.
Publicado: (2020)

High pretreatment serum CA19-9 level predicts a poor prognosis for patients with stage III colon cancer after curative resection and adjuvant chemotherapy
por: Zhou, Wenhao, et al.
Publicado: (2019)

Change in clinical outcomes during the transition of adjuvant chemotherapy for stage III colorectal cancer
por: Osumi, Hiroki, et al.
Publicado: (2017)

The value of adjuvant chemotherapy in stage II/III colorectal signet ring cell carcinoma
por: Zhao, Zhuang, et al.
Publicado: (2020)

The efficacy of oxaliplatin combination adjuvant chemotherapy for elderly patients with stage III colorectal cancer
por: Hayashi, Naomi, et al.
Publicado: (2020)

Association between diabetes and adjuvant chemotherapy implementation in patients with stage III colorectal cancer
por: Kanehara, Rieko, et al.
Publicado: (2022)

Frailty is an independent risk factor for recurrence and mortality following curative resection of stage I–III colorectal cancer
por: Mima, Kosuke, et al.
Publicado: (2020)

Survival impact of microsatellite instability in stage II gastric cancer patients who received S-1 adjuvant monotherapy after curative resection
por: Sato, Chihiro, et al.
Publicado: (2023)

Preoperative controlling nutritional status (CONUT) score as a predictor of long-term outcome after curative resection followed by adjuvant chemotherapy in stage II-III gastric Cancer
por: Liu, Xuechao, et al.
Publicado: (2018)

Novel prognostic prediction models for patients with stage IV colorectal cancer after concurrent curative resection
por: Miyoshi, N, et al.
Publicado: (2016)

Prognostic implication of ABC transporters and cancer stem cell markers in patients with stage III colon cancer receiving adjuvant FOLFOX-4 chemotherapy
por: Han, Song-Hee, et al.
Publicado: (2019)

Precision medicine for adjuvant chemotherapy of resected colorectal cancer
por: Miyamoto, Yuji, et al.
Publicado: (2020)

Intra-arterial chemotherapy improved survival of stage 2–3 gallbladder cancer after curative resection
por: Chen, Cheng, et al.
Publicado: (2018)

Prognosis of stage III colorectal carcinomas with FOLFOX adjuvant chemotherapy can be predicted by molecular subtype
por: Kwon, Yujin, et al.
Publicado: (2017)

Irregular delay of adjuvant chemotherapy correlated with poor outcome in stage II-III colorectal cancer
por: Chen, Yuanyuan, et al.
Publicado: (2022)

ctDNA guided adjuvant chemotherapy versus standard of care adjuvant chemotherapy after curative surgery in patients with high risk stage II or stage III colorectal cancer: a multi-centre, prospective, randomised control trial (TRACC Part C)
por: Slater, Susanna, et al.
Publicado: (2023)

Optimal Time of Initiating Adjuvant Chemotherapy After Curative Surgery in Colorectal Cancer Patients
por: Kang, Kyu Min, et al.
Publicado: (2013)

The optimal time of starting adjuvant chemotherapy after curative surgery in patients with colorectal cancer
por: Yang, Yuchong, et al.
Publicado: (2023)

Survival after curative resection for stage I colorectal mucinous adenocarcinoma
por: Huang, Liang, et al.
Publicado: (2022)

Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy
por: Lee, Kyung-Hun, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_cqvad31erqs53eh4f8rsibgnu0